URGN Financials
UroGen Pharma Ltd - Financial statements & key metrics
Stock Price
$44.42
Market Cap
$1.61B
P/E Ratio
-55.5
EPS
$-0.80
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$24.57M
Gross Profit
-
Operating Income
-
Net Income
$-37.51M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$285.71M
Total Liabilities
$294.51M
Shareholders Equity
-
Cash & Equivalents
$171.99M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-96.77M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-94.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is URGN revenue?
URGN's most recent quarterly revenue was $24.57M. Annual revenue can be calculated by summing the four most recent quarters.
Is URGN profitable?
URGN reported a loss of $37.51M in the most recent quarter. The net profit margin is -94.8%.
What is URGN market cap?
URGN has a market capitalization of $1.61B, making it a small-cap stock.
Does URGN have debt?
View URGN's balance sheet for debt information.
What is URGN cash flow?
Cash flow data is available in the full financial statements.